Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Thane Jones
Institution:
Collaborations Pharmaceuticals (United States)
Observed institution:
Collaborations Pharmaceuticals (United States)
ORCID:
0000-0001-9670-0383
Observed ORCID:
0000-0001-9670-0383
OpenAlex ID:
A5064693328
Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral Activity
2023
·
Thane Jones
, Natalia Monakhova
, et al.
·
ACS Omega
·
14
PDF
N-Phenyl-1-(phenylsulfonyl)-1H-1,2,4-triazol-3-amine as a New Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor
2023
·
Thomas Lane
, Vadim Makarov
, et al.
·
Journal of Medicinal Chemistry
·
14
PDF
Predicting the Hallucinogenic Potential of Molecules Using Artificial Intelligence
2024
·
Fabio Urbina
, Thane Jones
, et al.
·
ACS Chemical Neuroscience
·
12
PDF
1-Sulfonyl-3-amino-1H-1,2,4-triazoles as Yellow Fever Virus Inhibitors: Synthesis and Structure–Activity Relationship
2023
·
Elena Kazakova
, Thomas R. Lane
, et al.
·
ACS Omega
·
10
PDF
Antiviral Evaluation of Dispirotripiperazines against Hepatitis B Virus
2023
·
Thane Jones
, John E. Tavis
, et al.
·
Journal of Medicinal Chemistry
·
9
PDF
Discovery of Dual Targeting GSK-3β/HIV-1 Reverse Transcriptase Inhibitors as Neuroprotective Antiviral Agents
2024
·
Thane Jones
, Renuka Raman
, et al.
·
ACS Chemical Neuroscience
·
5
PDF
Discovery of a selective 5-HT2C agonist by generative machine learning using MegaSyn with applications to treating opioid use disorder
2025
·
Thane Jones
, Joshua S. Harris
, et al.
·
Neurotherapeutics
·
1
PDF
A Medicinal Chemistry Perspective on Generative AI Synthesis Predictions
2024
·
Thane Jones
, Sean Ekins
·
CRC Press eBooks
Show more works
View as search
Works count:
8
Citation count:
65
H-index:
5
I10-index:
4
Year
Topic
Type